Dr. Sundby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bldg 10
Bethesda, MD 20892Phone+1 301-219-3758Fax+1 301-451-7010
Education & Training
- National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2017
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2021
- University of California San FranciscoPediatrics, Residency, 2014 - 2017
- Vanderbilt University School of MedicineClass of 2014, MD
- Haverford CollegeBS, Biology, 2004 - 2008
Certifications & Licensure
- MD State Medical License 2018 - 2025
- CA State Medical License 2016 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Francis Collins Scholar Award in Neurofibromatosis NTAP, 2023-2025
- Make NF Visible Researcher Award Children's Tumor Foundation, 2024
- NextGen Award Children's Cancer Foundation, Giant Food, 2020
- Join now to see all
Publications & Presentations
PubMed
- Brain Metastasis in Pediatric Patients with Osteosarcoma.Jacob Murphy, R Taylor Sundby, Erin E Resch, Ruyan Rahnama, Kathryn M Lemberg
Current Oncology. 2024-11-09 - 1 citationsConsensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis type 1 (NF1).Calixto-Hope G Lucas, Andrea M Gross, Carlos G Romo, Carina A Dehner, Alexander J Lazar
Neuro-Oncology. 2024-11-06 - Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.R Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, Paul A Jones, Sana Z Mahmood
Clinical Cancer Research. 2024-10-01
Journal Articles
- Understanding the Potential of Early-Cancer Detection Using Liquid Biopsy in Patients With Hereditary Cancer SyndromesR. Taylor Sundby, MD, Jeffrey J. Szymanski, MD, PhD, Paul A. Jones, Aadel A. Chaudhuri, MD, PhD, Jack F. Shern, MD, and Angela C. Hirbe, MD, PhD, ASCO Daily News, 3/1/2024
Abstracts/Posters
- Cell free DNA analysis for early detection of malignant transformation in patients with neurofibromatosis type 1 (NF1)R. Taylor Sundby, MD, Children’s Tumor Foundation NF Conference, Virtual, 2020
- Genetic and epigenetic determinants of breast cancerR. Taylor Sundby, Certificate Program in Molecular Medicine Symposium, Vanderbilt-Ingram Cancer Center Retreat and Medical Scholars Research Day, Nashville, TN, 2013
- Normal human islets form amyloid in vitro and in vivoR. Taylor Sundby, NIDDK Medical Student Research National Symposium, Nashville, TN, 2010
- Join now to see all
Lectures
- Applications of cell free DNA in cancer predisposition (Branch Rounds)National Cancer Institute: Division of Cancer Epidemiology and Genetics, Bethesda, MD - 2020
- Updates on Immune Thrombocytopenic Purpura (Johns Hopkins Pediatric Trends, Invited Speaker)Baltimore, MD - 2019
- Investigative and Clinical Applications of Cell Free DNA (Branch Rounds)National Institute of Diabetes and Kidney Diseases: Metabolic Diseases Branch, Bethesda, MD - 2019
Grant Support
- Leveraging Clinical Testing to Establish a Foundational cfDNA Dataset for Neurofibromatosis Type 1 Translational ResearchChildren's Tumor Foundation2025–2028
- Preclinical–clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1NIH U012022–2027
- Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumorsNIH U012021–2026
- Utilization of Cell-Free DNA Liquid Biopsy for Diagnosis and Monitoring of Tumor Evolution in MPNSTChildren's Tumor Foundation2022–2025
- Multi-omic liquid biopsy analysis for early detection of malignant transformation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 (NF1)Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research2022–2025
- Dissecting the circulating proteome in NF1-associated peripheral nerve sheath tumorsChildren's Tumor Foundation2022–2024
- A pilot study incorporating prospective PET-CT imaging with peripheral blood next-generation sequencing and cell-free DNA to identify and optimize outcomes of CAR T-cell therapy in extramedullary B-ceChildren's Cancer Foundation2022–2023
- Cell free DNA analysis for early detection of malignant transformation in patients with neurofibromatosis type 1 (NF1)The Children’s Cancer Foundation (CCF) and Giant Food NextGen Award2020–2021
Professional Memberships
- Children's Oncology GroupMember
- Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS)Member
Other Languages
- Spanish
External Links
- Faculty Profilehttps://ccr.cancer.gov/staff-directory/russell-taylor-sundby
- Orcidhttps://orcid.org/0000-0001-8485-0026
- LinkedInhttps://www.linkedin.com/in/russellsundby
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: